The trajectory of companies tied to blockbuster drugs like Viagra presents a nuanced investment landscape . While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key markets has introduced significant risk . Investors are now grappling with the impact of generic competition ,